LoginSignup
Maravai Lifescie logo

Maravai Lifescie

Stock
Stock
ISIN: US56600D1072
Ticker: MRVI
US56600D1072
MRVI

Price

Price

CHART BY

Frequently asked questions

What is Maravai Lifescie's market capitalization?

The market capitalization of Maravai Lifescie is $761.70M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Maravai Lifescie?

Maravai Lifescie's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.649. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Maravai Lifescie's stock?

Currently, 15 analysts cover Maravai Lifescie's stock, with a consensus target price of $8.977. Analyst ratings provide insights into the stock's expected performance.

What is Maravai Lifescie's revenue over the trailing twelve months?

Over the trailing twelve months, Maravai Lifescie reported a revenue of $276.92M.

What is the EBITDA for Maravai Lifescie?

Maravai Lifescie's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $14.17M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Maravai Lifescie?

Maravai Lifescie has a free cash flow of -$10.71M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Maravai Lifescie have, and what sector and industry does it belong to?

Maravai Lifescie employs approximately 650 people. It operates in the Health Care sector, specifically within the Biotechnology industry.

What is the free float of Maravai Lifescie's shares?

The free float of Maravai Lifescie is 117.45M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$761.70M
EPS (TTM) 
-$1.649
Free Float 
117.45M
Revenue (TTM) 
$276.92M
EBITDA (TTM) 
$14.17M
Free Cashflow (TTM) 
-$10.71M

Pricing

1D span
$5.326$5.613
52W span
$4.275$11.56

Analyst Ratings

The price target is $8.977 and the stock is covered by 15 analysts.

Buy

8

Hold

6

Sell

1

Information

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

Employees
650
Industries
Biotechnology
Sector
Health Care

Identifier

ISIN
US56600D1072
Primary Ticker
MRVI

Knockouts

Join the conversation
Sign upLogin